Corporate News Report – Swedencare AB
Swedencare AB (ticker SECARE.ST) closed the trading day on Friday, 23 September 2026, at SEK 19.70, reflecting a decline of 20.17 % from the prior session. At 09:20 PM Central Europe, the stock was the most liquid security among the company’s shares, with a trading volume of approximately SEK 63.5 million and a circulating supply of 159.8 million shares. The firm’s market capitalisation stood at SEK 3.10 billion.
Recent Price and Technical Overview
- Current price: SEK 19.70
- Last 24‑hour change: –20.17 %
- 200‑day simple moving average: SEK 25.10
- 52‑week high: SEK 40.40 (27 October 2025)
- 52‑week low: SEK 18.54 (21 October 2026)
The recent slide in price has brought Swedencare’s valuation below its 200‑day moving average, a technical indicator often viewed as a warning signal by short‑term traders. The 52‑week low, recorded just a month prior, suggests a tightening of the trading range.
Brokerage Target‑Price Adjustments
Two prominent Swedish brokerage houses have updated their target prices, signalling a more cautious outlook for the near term:
| Broker | New Target | Old Target | Recommendation |
|---|---|---|---|
| Handelsbanken Capital Markets | SEK 25.00 | SEK 36.00 | Buy |
| Pareto Securities | SEK 30.00 | SEK 35.00 | Buy |
Both firms maintain a purchase recommendation, but the lowered targets indicate an expectation that the stock may struggle to reach previous highs without a substantive shift in fundamentals.
Earnings Snapshot
In its latest earnings presentation, Swedencare reported:
- A modest increase in earnings per share (EPS) compared to the same quarter last year.
- A slight rise in sales relative to the preceding year’s quarter.
These figures suggest that the company’s core operations remain stable, yet the growth pace appears restrained. The combination of modest earnings growth and lowered brokerage targets points to a market perception that short‑term price appreciation will be limited until a more pronounced turnaround is evident.
Market Activity in the Broader Context
To gauge Swedencare’s performance relative to peers, the following snapshot of related stocks shows how they behaved in the last 24 hours:
- Loomis (LOOMIS.ST) – down 0.88 %, trading at SEK 545.00; market cap SEK 3.60 bn; P/E 20.32.
- Rejlers (REJL‑B.ST) – up 1.59 %, trading at SEK 146.60; market cap SEK 3.30 bn; P/E 19.03. Rejlers has secured a new project with Viscaria for a pumping station in the Viscaria mine near Kiruna, with planning slated for late 2026 and execution expected through autumn 2027. A potential merger with Multiconsult is also under discussion, which could yield cost synergies.
- Polestar Automotive‑CL A Ads (PSNY) – down 2.65 %, trading at USD 3.64; market cap USD 339.5 mn; P/E 0.01.
- Nivika Fastigheter (NIVI‑B.ST) – down 0.14 %, trading at SEK 34.75; market cap SEK 3.10 bn; P/E 8.90.
- Xano Industri (XANO‑B.ST) – down 0.31 %, trading at SEK 51.40; market cap SEK 3.00 bn; P/E 17.88.
While most of these peers have seen modest movements, Swedencare’s steep decline stands out. The broader sector’s mixed performance underscores the importance of evaluating company‑specific catalysts rather than relying solely on industry trends.
Company Profile
Swedencare AB is a health‑care company headquartered in Malmö, Sweden. Its core business revolves around the development and manufacturing of pet‑care products, including nutritional supplements, dental care items, and other related goods. The company serves a global customer base through its online platform at www.swedencare.se . Swedencare is listed on the Stockholm Stock Exchange and is subject to Swedish regulatory oversight.
Summary: Swedencare AB’s recent performance reflects a sharp price decline that has pushed the stock below its 200‑day moving average. Updated brokerage target prices indicate a cautious short‑term outlook, despite modest EPS and sales growth. In contrast to the relatively stable or mildly positive moves of peers such as Rejlers, Swedencare’s trajectory suggests that investors may need to wait for stronger earnings momentum or strategic catalysts before expecting a rebound.
